scispace - formally typeset
M

Marjolein van Egmond

Researcher at VU University Amsterdam

Publications -  102
Citations -  15053

Marjolein van Egmond is an academic researcher from VU University Amsterdam. The author has contributed to research in topics: Immune system & Antibody. The author has an hindex of 39, co-authored 86 publications receiving 12709 citations. Previous affiliations of Marjolein van Egmond include VU University Medical Center & Utrecht University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Macrophages in skin injury and repair.

Babak Mahdavian Delavary, +4 more
- 01 Jul 2011 - 
TL;DR: This review summarizes macrophage function in skin injury repair, thereby providing more insight in macrophages function in wound healing and possible interventions in this process.
Journal ArticleDOI

IgA and the IgA Fc receptor.

Marjolein van Egmond, +5 more
- 01 Apr 2001 - 
TL;DR: New insights in the roles of IgA and FcalphaRI are addressed and a model integrating the various functions of Ig a in immunity is discussed, and a new insights inThe role of the myeloid IgA receptor in immunity and its role in innate and adaptive immunity is addressed.
Journal ArticleDOI

CD47–signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction

Xi Wen Zhao, +14 more
- 08 Nov 2011 - 
TL;DR: It is shown that antibody-mediated killing of tumor cells is limited by a mechanism involving the interaction between tumor cell-expressed CD47 and the inhibitory receptor signal regulatory protein-α (SIRPα) on myeloid cells.